Cardiovascular implantable electronic devices (CIEDs) have expanded in number and
complexity since their introduction in 1958 and now include cardiac pacemakers, implantable …

Heart failure remains a common diagnosis, especially in older individuals. It continues to be
associated with significant morbidity and mortality, but major advances in both diagnosis …

The Canadian Hypertension Education Program reviews the hypertension literature annually
and provides detailed recommendations regarding hypertension diagnosis, assessment, …

Background In patients with type 2 diabetes, inhibitors of sodium–glucose cotransporter 2 (SGLT2)
reduce the risk of a first hospitalization for heart failure, possibly through glucose-…

Background Nesiritide is approved in the United States for early relief of dyspnea in patients
with acute heart failure. Previous meta-analyses have raised questions regarding renal …

Context Findings from previous studies of the effects of exercise training on patient-reported
health status have been inconsistent. Objective To test the effects of exercise training on …

Since the inception of the Canadian Cardiovascular Society heart failure (HF) guidelines in
2006, much has changed in the care for patients with HF. Over the past decade, the HF …

Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis,
assessment, prevention, and treatment of hypertension in adults and children. This year, …

Background The selective cardiac myosin activator omecamtiv mecarbil has been shown to
improve cardiac function in patients with heart failure with a reduced ejection fraction. Its …

Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force
provides annually updated, evidence-based recommendations to guide the diagnosis, …